UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 48

Sortiert nach

Alterations of the Notch pathway in lung cancer

Proceedings of the National Academy of Sciences - PNAS, 2009-12, Vol.106 (52), p.22293-22298

2009

Volltextzugriff (PDF)

Delocalization and destabilization of the Arf tumor suppressor by the leukemia-associated NPM mutant

Cancer research (Chicago, Ill.), 2006-03, Vol.66 (6), p.3044-3050

2006

Volltextzugriff (PDF)

Two Missense Variants Detected in Breast Cancer Probands Preventing BRCA2-PALB2 Protein Interaction

Frontiers in oncology, 2018-10, Vol.8, p.480-480

2018

Volltextzugriff (PDF)

OncoPan ® : An NGS-Based Screening Methodology to Identify Molecular Markers for Therapy and Risk Assessment in Pancreatic Ductal Adenocarcinoma

Biomedicines, 2022-05, Vol.10 (5), p.1208

2022

Volltextzugriff (PDF)

The lymphoma-associated NPM-ALK oncogene elicits a p16INK4a/pRb-dependent tumor-suppressive pathway

Blood, 2011-06, Vol.117 (24), p.6617-6626

2011

Volltextzugriff (PDF)

Ultradeep sequencing of a human ultraconserved region reveals somatic and constitutional genomic instability

PLoS biology, 2010-01, Vol.8 (1), p.e1000275-e1000275

2010

Volltextzugriff (PDF)

Germline mutations in BRIP1 and PALB2 in Jewish high cancer risk families

Familial cancer, 2012-09, Vol.11 (3), p.483-491

2012

Volltextzugriff (PDF)

Identification of six new susceptibility loci for invasive epithelial ovarian cancer

Nature genetics, 2015-02, Vol.47 (2), p.164-171

2015

Volltextzugriff (PDF)

Evidence for interaction between human PRUNE and nm23-H1 NDPKinase

Oncogene, 1999-12, Vol.18 (51), p.7244-7252

1999

Volltextzugriff (PDF)

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

Cancer epidemiology, biomarkers & prevention, 2012-01, Vol.21 (1), p.134-147

2012

Volltextzugriff (PDF)

Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk

PLoS genetics, 2013, Vol.9 (3), p.e1003212-e1003212

2013

Volltextzugriff (PDF)

De novo germline pathogenic variant in Lynch Syndrome: A rare event or the tip of the iceberg?

Tumori, 2024-02, Vol.110 (1), p.69-73

2024

Volltextzugriff (PDF)

The p53 Arg72Pro and Ins16bp polymorphisms and their haplotypes are not associated with breast cancer risk in BRCA-mutation negative familial cases

Cancer detection and prevention, 2008-01, Vol.32 (2), p.140-143

2008

Volltextzugriff (PDF)

FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor

Human molecular genetics, 2015-09, Vol.24 (18), p.5345-5355

2015

Volltextzugriff (PDF)

Development, technical validation, and clinical application of a multigene panel for hereditary gastrointestinal cancer and polyposis

Tumori, 2019-08, Vol.105 (4), p.338-352

2019

Volltextzugriff (PDF)

Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation

Nature communications, 2014-09, Vol.4 (1), p.4999, Article 4999

2014

Volltextzugriff (PDF)

DEK Expression is Controlled by E2F and Deregulated in Diverse Tumor Type

Cell cycle (Georgetown, Tex.), 2006-06, Vol.5 (11), p.1202-1207

2006

Volltextzugriff (PDF)

DEK Expression is controlled by E2F and deregulated in diverse tumor types

Cell cycle (Georgetown, Tex.), 2006-06, Vol.5 (11), p.1202-1207

2006

Volltextzugriff (PDF)

Haplotype analyses of the c.1027C>T and c.2167_2168delAT recurrent truncating mutations in the breast cancer-predisposing gene PALB2

Breast cancer research and treatment, 2016-11, Vol.160 (1), p.121-129

2016

Volltextzugriff (PDF)

Haplotype analyses of the c.1027CT and c.2167_2168delAT recurrent truncating mutations in the breast cancer-predisposing gene PALB2

Breast cancer research and treatment, 2016-11, Vol.160 (1), p.121

2016

Volltextzugriff (PDF)

The hidden genomic landscape of acute myeloid leukemia: subclonal structure revealed by undetected mutations

Blood, 2015-01, Vol.125 (4), p.600-605

2015

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(47)
Berichte
(1)

Sprache

Englisch
(48)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Plos Genetics
(6)
Blood
(4)
Breast Cancer Research And Treatment
(4)
Nature Communications
(3)
Cell Cycle
(2)
Human Molecular Genetics
(2)
Human Mutation
(2)
Plos Biology
(2)
Tumori
(2)
Biomedicines
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Alterations of the Notch pathway in lung cancer

Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+ AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance

Delocalization and destabilization of the Arf tumor suppressor by the leukemia-associated NPM mutant

Analysis of Italian BRCA1/2 Pathogenic Variants Identifies a Private Spectrum in the Population from the Bergamo Province in Northern Italy

Two Missense Variants Detected in Breast Cancer Probands Preventing BRCA2-PALB2 Protein Interaction

OncoPan ® : An NGS-Based Screening Methodology to Identify Molecular Markers for Therapy and Risk Assessment in Pancreatic Ductal Adenocarcinoma

The lymphoma-associated NPM-ALK oncogene elicits a p16INK4a/pRb-dependent tumor-suppressive pathway

Ultradeep sequencing of a human ultraconserved region reveals somatic and constitutional genomic instability

Germline mutations in BRIP1 and PALB2 in Jewish high cancer risk families

Identification of six new susceptibility loci for invasive epithelial ovarian cancer

Evidence for interaction between human PRUNE and nm23-H1 NDPKinase

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk

De novo germline pathogenic variant in Lynch Syndrome: A rare event or the tip of the iceberg?

The p53 Arg72Pro and Ins16bp polymorphisms and their haplotypes are not associated with breast cancer risk in BRCA-mutation negative familial cases

FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor

Development, technical validation, and clinical application of a multigene panel for hereditary gastrointestinal cancer and polyposis

Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation

DEK Expression is Controlled by E2F and Deregulated in Diverse Tumor Type

DEK Expression is controlled by E2F and deregulated in diverse tumor types

Identification of fifteen novel germline variants in the BRCA1 3′UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target site

Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia

Haplotype analyses of the c.1027C>T and c.2167_2168delAT recurrent truncating mutations in the breast cancer-predisposing gene PALB2

Haplotype analyses of the c.1027CT and c.2167_2168delAT recurrent truncating mutations in the breast cancer-predisposing gene PALB2

The hidden genomic landscape of acute myeloid leukemia: subclonal structure revealed by undetected mutations

Suchergebnisse filtern